Table 2:

Procedural characteristics and outcome measures stratified by SH seen on FDCT

Total NaSH 0–IVTotal NaSH 0Total NaSH I–IVP Value
Procedural characteristics
 No. of passes, (median) [lq, uq]2182.0 [1.0–3.0]1211.0 [1.0–2.0]972.0 [1.0–4.0]<.001
 Most distal device position, No. (%)223123100<.001
  Large vessel34 (15.2%)30 (24.4%)4 (4.0%)
  Medium vessel140 (62.8%)72 (58.5%)68 (68.0%)
  Distal vessel49 (22.0%)21 (17.1%)28 (28.0%)
 Amount of contrast medium (mL) (median) [lq, uq]217120 [100–180]119110 [90–160]98133 [100–190].035
 Active extravasation seen on DSA, No. (%)22313 (5.8%)1230 (0.0%)10013 (13.0%)<.001
 Parenchymal hyperdensities on FDCT, No. (%)223110 (49.3%)12367 (54.5%)10043 (43.0%).09
 eTICI score, No. (%)22112398.014
  014 (6.3%)3 (2.4%)11 (11.2%)
  14 (1.8%)1 (0.8%)3 (3.1%)
  2a8 (3.6%)6 (4.9%)2 (2.0%)
  2b5028 (12.7%)13 (10.6%)15 (15.3%)
  2b6736 (16.3%)16 (13.0%)20 (20.4%)
  2c50 (22.6%)32 (26.0%)18 (18.4%)
  381 (36.7%)52 (42.3%)29 (29.6%)
Outcome measures
 mRS at 3 months, (median) [lq, uq]1963.0 [1.0–6.0]1072.0 [1.0–5.0]893.0 [1.0–6.0].21
 NIHSS at 24 hours (median) [lq, uq]2138.0 [3.0–16.0]1208.0 [3.0–16.0]936.0 [3.0–15.0].76
  • Note:—lq indicates lower quartile; uq, upper quartile.

  • a N indicates number of patients without missing data.